CRISPR Therapeutics AG
NASDAQ:CRSP

Watchlist Manager
CRISPR Therapeutics AG Logo
CRISPR Therapeutics AG
NASDAQ:CRSP
Watchlist
Price: 40.94 USD 1.14% Market Closed
Market Cap: 3.5B USD
Have any thoughts about
CRISPR Therapeutics AG?
Write Note

Cash Flow Statement

Cash Flow Statement
CRISPR Therapeutics AG

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024
Operating Cash Flow
Net Income
(26)
(31)
(44)
(53)
(23)
(36)
(41)
(51)
(68)
(75)
(91)
(117)
(165)
(185)
(200)
(11)
67
46
20
(211)
(349)
(392)
447
412
378
312
(634)
(681)
(650)
(524)
(416)
(354)
(154)
(217)
(266)
(240)
Depreciation & Amortization
0
0
0
1
1
2
2
3
3
3
3
3
4
4
4
4
5
6
7
8
9
10
11
14
18
21
25
25
24
23
21
21
20
20
20
19
Stock-Based Compensation
4
5
8
10
11
13
13
16
19
21
26
29
35
39
42
45
44
49
53
59
66
74
87
96
102
106
103
101
98
93
90
85
81
80
81
0
Other Non-Cash Items
4
0
4
6
(35)
(29)
(29)
(26)
21
24
29
48
55
59
62
52
34
38
41
44
68
77
92
106
117
124
122
118
110
99
89
76
67
58
55
55
Change in Working Capital
81
82
80
80
2
(5)
(3)
(0)
(25)
(21)
(19)
(16)
11
6
7
(20)
(48)
(41)
(13)
6
33
19
(0)
12
27
47
42
70
20
51
(37)
(21)
(194)
(20)
70
(23)
Cash from Operating Activities
59
N/A
51
-14%
40
-21%
33
-17%
(55)
N/A
(69)
-24%
(71)
-3%
(75)
-5%
(70)
+6%
(69)
+1%
(79)
-13%
(83)
-5%
(96)
-16%
(117)
-22%
(128)
-10%
25
N/A
57
+127%
48
-15%
55
+15%
(154)
N/A
(238)
-55%
(287)
-20%
549
N/A
544
-1%
539
-1%
505
-6%
(445)
N/A
(468)
-5%
(496)
-6%
(352)
+29%
(343)
+3%
(278)
+19%
(260)
+6%
(159)
+39%
(122)
+24%
(189)
-55%
Investing Cash Flow
Capital Expenditures
(1)
(1)
(2)
(3)
(3)
(6)
(6)
(8)
(8)
(5)
(4)
(2)
(3)
(3)
(5)
(7)
(7)
(9)
(10)
(13)
(18)
(22)
(47)
(79)
(82)
(90)
(71)
(40)
(37)
(25)
(20)
(17)
(12)
(10)
(5)
(2)
Other Items
0
20
20
20
35
15
0
15
(1)
0
0
0
0
0
0
0
8
0
0
(317)
(523)
(684)
(949)
(1 152)
(954)
(892)
(673)
(52)
(222)
(1)
267
298
387
169
(180)
(465)
Cash from Investing Activities
(1)
N/A
19
N/A
18
-5%
17
-5%
32
+92%
9
-72%
9
-2%
7
-23%
(8)
N/A
(6)
+33%
(5)
+14%
(2)
+58%
(3)
-40%
(3)
-18%
(5)
-52%
(7)
-34%
1
N/A
(1)
N/A
(2)
-233%
(330)
-16 395%
(541)
-64%
(706)
-30%
(996)
-41%
(1 231)
-24%
(1 035)
+16%
(982)
+5%
(745)
+24%
(92)
+88%
(259)
-182%
(26)
+90%
247
N/A
281
+14%
375
+34%
159
-58%
(185)
N/A
(468)
-153%
Financing Cash Flow
Net Issuance of Common Stock
59
54
62
61
115
115
55
55
3
128
131
319
316
216
242
125
431
406
466
908
1 016
1 241
1 160
657
251
36
38
42
39
33
40
26
63
363
346
354
Net Issuance of Debt
38
73
73
73
35
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
(0)
(0)
(0)
(5)
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Cash from Financing Activities
97
N/A
126
+31%
134
+6%
130
-3%
183
+41%
148
-19%
88
-41%
93
+6%
3
-97%
128
+4 819%
131
+2%
319
+143%
316
-1%
216
-32%
242
+12%
125
-48%
431
+245%
406
-6%
466
+15%
908
+95%
1 016
+12%
1 241
+22%
1 160
-7%
657
-43%
251
-62%
36
-86%
38
+6%
42
+13%
39
-9%
33
-13%
40
+19%
26
-34%
63
+139%
363
+480%
346
-5%
354
+2%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(0)
(0)
(0)
(0)
0
0
0
0
(0)
0
Net Change in Cash
155
N/A
196
+26%
192
-2%
180
-7%
160
-11%
88
-45%
25
-71%
25
-2%
(76)
N/A
53
N/A
48
-10%
234
+392%
217
-7%
96
-56%
109
+14%
143
+32%
489
+241%
454
-7%
520
+14%
425
-18%
237
-44%
248
+5%
713
+188%
(30)
N/A
(246)
-721%
(442)
-80%
(1 152)
-161%
(518)
+55%
(716)
-38%
(345)
+52%
(56)
+84%
29
N/A
177
+506%
363
+105%
39
-89%
(302)
N/A
Free Cash Flow
Free Cash Flow
58
N/A
50
-15%
38
-24%
30
-21%
(58)
N/A
(75)
-28%
(77)
-3%
(83)
-7%
(78)
+6%
(75)
+4%
(83)
-11%
(85)
-2%
(99)
-17%
(121)
-22%
(133)
-11%
18
N/A
50
+173%
40
-21%
45
+14%
(167)
N/A
(257)
-54%
(309)
-20%
502
N/A
465
-7%
457
-2%
414
-9%
(516)
N/A
(509)
+1%
(533)
-5%
(377)
+29%
(363)
+4%
(295)
+19%
(272)
+8%
(169)
+38%
(127)
+25%
(191)
-50%

See Also

Discover More